HYVET 2: Treatment of white coat HYpertension in the Very Elderly
Research type
Research Study
Full title
A Multi-Centred, Open Label, Randomised Study Assessing the Cardiovascular Outcomes Following Treatment of White Coat Hypertension with Established Anti-Hypertensive Drugs versus Standard of Care in the Very Elderly - Feasibility Study
IRAS ID
233928
Contact name
Chakravarthi Rajkumar
Contact email
Sponsor organisation
University of Sussex
Eudract number
2017-004004-22
Duration of Study in the UK
3 years, 6 months, 1 days
Research summary
The HYVET 2 study is looking at whether it is possible to treat White Coat Hypertension in older patients with blood pressure lowering drugs. White Coat Hypertension is a raised blood pressure when you are in a clinic setting however, your blood pressure at home is normal. At present, White Coat Hypertension isn’t treated, however, previous research has suggested that there might be some benefit to treating White Coat Hypertension in relation to conditions affecting the heart and blood vessels. We want to investigate this further.
The study is being run at a number of GP practices throughout the UK. We are hoping to get 100 participants to take part in the trial, half of which will be given blood pressure lowering treatment for 12 months and the other half will receive no treatment for blood pressure lowering. There will be visits required to the GP every 2 months throughout the 12 month period and participants will be asked to keep a diary of any ailments that they experience during the study.
The study is funded by Dunhill Medical Trust.REC name
London - Westminster Research Ethics Committee
REC reference
18/LO/0104
Date of REC Opinion
16 Mar 2018
REC opinion
Further Information Favourable Opinion